Cynthia Brouse Robinson
Corporate Officer/Principal chez Epigenesis Pharmaceuticals LLC
Profil
Cynthia Brouse Robinson is currently the Vice President-Clinical Development at Epigenesis Pharmaceuticals LLC since 2002.
Previously, she worked as the Head-Clinical Drug Discovery at GSK Plc.
She holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from Sidney Kimmel Medical College.
Postes actifs de Cynthia Brouse Robinson
| Sociétés | Poste | Début |
|---|---|---|
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01/01/2002 |
Anciens postes connus de Cynthia Brouse Robinson
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formation de Cynthia Brouse Robinson
| University of California, Berkeley | Doctorate Degree |
| Sidney Kimmel Medical College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Epigenesis Pharmaceuticals LLC
Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ. | Health Technology |
